ClinConnect ClinConnect Logo
Search / Trial NCT06872853

Evaluation of Rare and Complex Tumours of the Thoraco-Abdominal and Soft Tissue District

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Mar 7, 2025

Trial Information

Current as of April 30, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on studying rare and complex tumors, specifically those found in the thoraco-abdominal area and soft tissues. The main goal is to collect detailed information about how these tumors are diagnosed, treated, and followed up over time. The study will look back at patient data from January 1, 2000, to September 28, 2017, and will also collect new information from September 29, 2017, to December 31, 2025.

If you or a family member has been diagnosed with a rare or complex malignant tumor and can provide informed consent, you may be eligible to participate in this study. There are no specific exclusions, meaning anyone fitting the criteria can join. Participants can expect to share their medical history and treatment details, which will help researchers better understand these rare conditions and improve future care. This study is currently recruiting participants, and all genders aged 65 and older are welcome to join.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients with histologic diagnosis of rare or highly complex malignant neoplasm
  • informed consent
  • Exclusion Criteria:
  • none

About Irccs Azienda Ospedaliero Universitaria Di Bologna

IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.

Locations

Bologna, Bo, Italy

Bologna, Bo, Italy

Patients applied

0 patients applied

Trial Officials

Maria A Pantaleo, MD

Principal Investigator

Oncology Unit, IRCCS AOUBO

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported